Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
71 Detection of ABL1 deletion without BCR-ABL rearrangement in ETP-ALL Department of Clinical Pathology Ahmed Makboul Ahmed Makboul 2024
72 Family strategies formanaging childhood cancer: Using traditional and complementarymedicine in Southern Egypt Department of Pediatric Oncology Ahmed Abdelwahab Faraag Mohammed 2024
73 Detection of ABL1 deletion without BCR-ABL rearrangement in ETP-ALL Department of Clinical Pathology Walaa Talaat Kamel 2024
74 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Dr. Shimaa Hassan Shabaan Hassan 2024
75 Detection of ABL1 deletion without BCR-ABL rearrangement in ETP-ALL Department of Clinical Pathology Dr. Doaa Fathi Hagag Ahmed 2024
76 Computed tomography perfusion as a predictor of gastric cancer grades Department of Radiology Dr. Hossam El-Din / Mostafa Kamel Mohamed 2024
77 Role of Irreversible Electroporation in Solid Abdominal Tumors Management Department of Radiology Prof. Amro Farouk ِAhmedMourad 2024
78 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Department of Medical Oncology Hadeer Mohamed Saad Elshazly 2024
79 Beta Endorphins, Interleukin 1 and Interleukin 38 in Covid Patients Associated with Neuropsychological Manifestations Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2024
80 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2024